Ranu Harneet, Jiang Jackson, Ming Pang Shiu
Dermatology unit, Block 6, Level 9, Singapore General Hospital, Singapore - 169 608, Singapore.
Indian J Dermatol. 2011 Jan;56(1):74-6. doi: 10.4103/0019-5154.77557.
This is a case series of allopurinol-induced toxic epidermal necrolysis. Revisiting the indications of using allopurinol in asymptomatic hyperuricemia and a critical reappraisal of the safety profile of allopurinol is done in this article. The report is based on case presented at a tertiary hospital in Singapore. The aim of this study is to highlight the fatal consequences of the indiscriminate use of allopurinol. We report four cases of toxic epidermal necrolysis from allopurinol, three of which resulted in death. Our aim is to highlight that allopurinol in all these cases was not indicated and prescribed for asymptomatic hyperuricemia. The incidence and potentially severe and lethal consequences of allopurinol hypersensitivity syndrome and toxic epidermal necrolysis could be kept to a minimum by strictly adhering to the established indications of allopurinol treatment.
这是一组别嘌醇诱发中毒性表皮坏死松解症的病例。本文对别嘌醇在无症状高尿酸血症中的使用指征进行了重新审视,并对别嘌醇的安全性进行了批判性重新评估。该报告基于新加坡一家三级医院呈现的病例。本研究的目的是强调别嘌醇滥用的致命后果。我们报告了4例别嘌醇所致中毒性表皮坏死松解症病例,其中3例死亡。我们的目的是强调,在所有这些病例中,别嘌醇并非用于无症状高尿酸血症的指征,也未针对此进行处方。严格遵循别嘌醇治疗的既定指征,可将别嘌醇超敏综合征和中毒性表皮坏死松解症的发生率以及潜在的严重和致命后果降至最低。